Carolyn S. Calfee, MD

Yale University, BA, 1991-1995, English
University of Pennsylvania, MD, 1995-1999, Medicine
University of California, San Francisco Internship/Residency, 1999-2002, Internal Medicine
University of California, San Francisco Chief Residency, 2002-2003, Internal Medicine
University of California, San Francisco Fellowship, 2003-2007, Pulmonary/Critical Care
University of California, San Francisco Masters in Clinical Research (expected), 2007-2009, Clinical Research

• PROFESSIONAL EXPERIENCE
• 1999-2002
  Internship and Residency, Internal Medicine, University of California, San Francisco
• 2002-2003
  Chief Medical Resident, Internal Medicine, Moffitt-Long Hospital, UCSF
• 2002-2003
  Clinical Instructor, Department of Medicine, UCSF
• 2002-2003
  Attending Physician, Medical Service, Moffitt-Long Hospital, UCSF
• 2003-2004
  Clinical Fellow, Pulmonary and Critical Care Division, UCSF
• 2005-2006
  Advanced Training in Clinical Research Program, UCSF Department of Epidemiology and Biostatistics
• 2005-2007
  Research Fellow, Pulmonary and Critical Care Division, UCSF
• 2007-
  Assistant Professor, Pulmonary and Critical Care Division, UCSF Dept of Medicine

• 1994
  Phi Beta Kappa, Yale University
• 1995
  Bachelor of Arts awarded magna cum laude, with Distinction in the Major
• 1998
  Alpha Omega Alpha, University of Pennsylvania School of Medicine
• 1999
  Julia M. Glasgow Award, University of Pennsylvania School of Medicine
• 1999
  Spencer Morris Prize, University of Pennsylvania School of Medicine
• 2000
  Intern of the Year, University of California, San Francisco, Department of Medicine
• 2005
  Walter Travel Award, American Lung Association

• Calfee CS, Matthay MA. Recent advances in mechanical ventilation. American Journal of Medicine. 2005; 118: 584-91.
• Matthay MA, Calfee CS. Therapeutic value of a lung protective ventilation strategy in acute lung injury. Chest 2005; 128(5): 3089-91.
• Calfee CS, Katz PP, Yelin EH, Iribarren C, Eisner MD. The influence of perceived control of asthma on health outcomes. Chest 2006; 130(5): 1312-18.
• Calfee CS, Shah SJ, Wolters PJ, Saint S, King TE. Anchors away. New England Journal of Medicine 2007, 356: 504-9.
• Calfee CS, Matthay MA. Non-ventilatory treatments for acute lung injury and the acute respiratory distress syndrome. Chest 2007; 131: 913-20.
• Calfee CS, Budev MM, Matthay MA, Church G, Brady S, Uchida T, Ishizaka A, Lara A, Ranes J, Arroliga AC. Plasma receptor for advanced glycation endproducts predicts duration of ICU stay and mechanical ventilation in patients following lung transplantation. J Heart Lung Transplant 2007; 26(7): 675-80.
• Calfee CS, Eisner MD, Ware LB, Thompson BT, Parsons PE, Wheeler AP, Korpak A, Matthay MA. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Critical Care Medicine 2007; 35(10): 2243-50. (Feature Article)
• Calfee CS, Ware LB. Biomarkers of lung injury in primary graft dysfunction following lung transplantation. Biomarkers in Medicine 2007; 1(2): 285-91.
• Matthay MA, Calfee CS. Aerosolized beta-adrenergic agonist therapy reduces pulmonary edema following lung surgery. Chest 2008; 133(4): 833-5.
• Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, Matthay MA. Plasma receptor for advanced glycation end-products and clinical outcomes in acute lung injury. Thorax 2008; 63(12): 1083-9.
• Calfee CS, Eisner MD, Parsons PE, Thompson BT, Matthay MA, Ware LB. Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intensive Care Medicine 2009; 35(2): 248-57.
• Briot R, Frank JA, Uchida T, Lee JW, Calfee CS, Matthay MA. Elevated levels of RAGE, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 2009; 135(2): 269-75.
• Suratt BT, Eisner MD, Calfee CS, Allard JB, Whittaker LA, Engelken DT, Petty JM, Trimarchi T, Gauthier L, Parsons PE. Plasma G-CSF levels and clinical outcomes in patients with acute lung injury. Critical Care Medicine, Epub ahead of print.
• Levitt JE, Bedi H, Calfee CS, Gould MK, Matthay MA. Identification of Early Acute Lung Injury at Initial Evaluation in an Acute Care Setting Prior to the Onset of Respiratory Failure. Chest, Epub ahead of print.
• Kropski JA, Fremont RD, Calfee CS, Ware LB. Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from critically ill patients with acute lung injury and the acute respiratory distress syndrome. Chest, Epub ahead of print.